- Home
- EWTX vs CIFR Comparison
EWTX vs CIFR Comparison
Compare EWTX & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- CIFR
- Stock Information
- Founded
- EWTX 2017
- CIFR 2021
- Country
- EWTX United States
- CIFR United States
- Employees
- EWTX N/A
- CIFR N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- CIFR Investment Bankers/Brokers/Service
- Sector
- EWTX Health Care
- CIFR Finance
- Exchange
- EWTX Nasdaq
- CIFR Nasdaq
- Market Cap
- EWTX 1.5B
- CIFR 1.2B
- IPO Year
- EWTX 2021
- CIFR N/A
- Fundamental
- Price
- EWTX $13.03
- CIFR $6.05
- Analyst Decision
- EWTX Buy
- CIFR Strong Buy
- Analyst Count
- EWTX 9
- CIFR 10
- Target Price
- EWTX $39.89
- CIFR $7.58
- AVG Volume (30 Days)
- EWTX 892.5K
- CIFR 39.4M
- Earning Date
- EWTX 08-07-2025
- CIFR 08-12-2025
- Dividend Yield
- EWTX N/A
- CIFR N/A
- EPS Growth
- EWTX N/A
- CIFR N/A
- EPS
- EWTX N/A
- CIFR N/A
- Revenue
- EWTX N/A
- CIFR $152,092,000.00
- Revenue This Year
- EWTX N/A
- CIFR $88.07
- Revenue Next Year
- EWTX N/A
- CIFR $68.21
- P/E Ratio
- EWTX N/A
- CIFR N/A
- Revenue Growth
- EWTX N/A
- CIFR N/A
- 52 Week Low
- EWTX $10.60
- CIFR $1.86
- 52 Week High
- EWTX $38.12
- CIFR $7.99
- Technical
- Relative Strength Index (RSI)
- EWTX 35.20
- CIFR 80.05
- Support Level
- EWTX $12.72
- CIFR $3.65
- Resistance Level
- EWTX $13.37
- CIFR $4.03
- Average True Range (ATR)
- EWTX 0.65
- CIFR 0.40
- MACD
- EWTX -0.16
- CIFR 0.20
- Stochastic Oscillator
- EWTX 24.22
- CIFR 87.34
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About CIFR Cipher Mining Inc.
Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.